iRhythm Posts 90-Cent Per-Share Loss for Third Quarter
IRTC sits 29% above its 52-week low of $100.7.
Summary
iRhythm reported a third-quarter loss of 90 cents per share, per Dow Jones Newswires, on revenue of $221.6M, up 14.9%. That revenue compares with the $224.2M booked in Q2 2026, when the company posted a near-breakeven net loss and beat estimates — so the swing back to a sizable per-share loss is the key number here. The quarter is the first full period including the $287.5M VitalConnect acquisition, which closed October 5 with $237.5M in cash plus up to 423 thousand shares, so integration costs and deal accounting are likely factors in the loss.
At the time of this announcement, IRTC was trading at $130.19 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $100.70 to $192.47. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.